AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Exicure, Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00GTJCSC3
1.05▼ 0.08 (-7.08%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
—
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
—
Trading Information
Previous Close
1.13
Day's Range
1.04 – 1.14
52-Week Range
0.94 – 9.48
Volume
55.3K
Avg Volume
44.0K
Share Statistics
Shares Outstanding
Employees
8
Exchange
XNAS
Listed
2018-05-09
Share count as of August 13, 2026

Exicure, Inc. Common Stock (XCUR) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Exicure, Inc. Common Stock (XCUR)
What is Exicure, Inc. Common Stock's Market Cap?
Exicure, Inc. Common Stock's Market Cap is $6.9M, based on as-reported figures from SEC (XBRL) filings.
What is Exicure, Inc. Common Stock's Revenue (TTM)?
Exicure, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Exicure, Inc. Common Stock's Net Income (TTM)?
Exicure, Inc. Common Stock's Net Income (TTM) is -$8.3M, based on as-reported figures from SEC (XBRL) filings.
What is Exicure, Inc. Common Stock's Diluted EPS (TTM)?
Exicure, Inc. Common Stock's Diluted EPS (TTM) is -1.27, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · XCURAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue:
Revenue
Total revenue——
YoY growth————
Operating expenses:
Research and development expense
General and administrative expense
Loss (Gain) on disposal of assets
Gain on early lease termination
Total operating expenses
% of revenue————
Operating (loss) income
% of revenue————
Other (expense) income, net:
Dividend income
Interest income
Gain on settlement of accounts payables
Change in fair value of contingent liability
Other expense, net:—
Total other expense, net
Net (loss) income before provision for income taxes
Provision for income taxes
Net (loss) income
% of revenue————
Net (loss) income per common share:
Basic (in dollars per share)
Diluted (in dollars per share)